Form 8-K - Current report:
SEC Accession No. 0001193125-19-195635
Filing Date
2019-07-17
Accepted
2019-07-17 16:07:02
Documents
1
Period of Report
2019-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d777840d8k.htm 8-K 18378
  Complete submission text file 0001193125-19-195635.txt   19589
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 19959221
SIC: 2834 Pharmaceutical Preparations